Twist Bioscience Corporation
TWST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $99 | $96 | $93 | $89 |
| % Growth | 3.1% | 3.5% | 4.6% | – |
| Cost of Goods Sold | $48 | $45 | $47 | $46 |
| Gross Profit | $51 | $51 | $46 | $43 |
| % Margin | 51.3% | 53.4% | 49.6% | 48.3% |
| R&D Expenses | $17 | $18 | $24 | $21 |
| G&A Expenses | $57 | $0 | $0 | $0 |
| SG&A Expenses | $64 | $63 | $64 | $56 |
| Sales & Mktg Exp. | $7 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $81 | $81 | $88 | $77 |
| Operating Income | -$30 | -$30 | -$42 | -$35 |
| % Margin | -30.2% | -31.4% | -44.8% | -39.1% |
| Other Income/Exp. Net | $3 | $51 | $2 | $3 |
| Pre-Tax Income | -$27 | $21 | -$39 | -$31 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$27 | $20 | -$39 | -$32 |
| % Margin | -27.4% | 21.2% | -42.4% | -35.6% |
| EPS | -0.45 | 0.34 | -0.66 | -0.53 |
| % Growth | -232.4% | 151.5% | -24.5% | – |
| EPS Diluted | -0.45 | 0.33 | -0.66 | -0.53 |
| Weighted Avg Shares Out | 60 | 60 | 60 | 59 |
| Weighted Avg Shares Out Dil | 60 | 61 | 60 | 59 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $3 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $6 | $6 | $6 | $6 |
| EBITDA | -$21 | $26 | -$33 | -$25 |
| % Margin | -21.1% | 27.5% | -35.1% | -28.3% |